amoxicillin; clarithromycin; vonoprazan fumarate · Phathom · NDA 215152
Voquezna Triple Pak
Earliest generic entry, as listed
3 May 2032
Blocked by exclusivity: GAIN.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9186411 | product | 11 Aug 2030 |
| US 7977488 | substance | 10 Apr 2030 |
Exclusivities · 2 unexpired
| GAIN | qualified infectious disease product | 3 May 2032 |
| NCE | new chemical entity (5 years) | 3 May 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 215152 · 001 · RLD | capsule, tablet, tablet, oral | 500MG;500MG;EQ 20MG BASE | 3 May 2032 |